- FDA Postpones Enforcement of DSCSA Transaction Data Exchange Until May 1
- Anatomy Of The National Drug Code
- DSCSA Exception Handling: A Preview of Your Next Surprise Headache
- Is An ASN Really The Best Way to Pass Lot-Based DSCSA Transaction Data?
- The Coming Battle Over Decommissioning At The Pharmacy
- DSCSA "Serial Numbers"
- Interoperability And The DSCSA
Archive for the ‘Supply Network Blog’ Category
I recently read in Pharmaceutical Commerce online magazine about the apparent resolution of the RxUSA lawsuit that had delayed implementaton of a couple of the pedigree provisions of the Federal PDMA (Prescription Drug Marketing Act). While Pharmaceutical Commerce did its usual great job of providing historical context, I thought it might be an appropriate topic for the RxTrace blog. But before I had time to document the history of the PDMA in my own words, Brian Daleiden beat me to it in the Supply Network Blog. So rather than writing my own version, I gladly refer you to his post. Between the Pharmaceutical Commerce article and Brian’s post, I have nothing more to say right now.
The Supply Network Blog is a fairly new publication of TraceLink, the successor to SupplyScape, my former employer. I look forward to hearing more from their blog in the future so I recently subscribed. Check it out and see what you think.
RxTrace is my go-to source for information surrounding the implementation and implications of the Drug Quality and Security Act.
RxTrace is informative and well-written. It’s my ‘go to’ source for information on serialization and DSCSA.
RxTrace offers unique context and focus on our industry.
Rx Trace is an excellent source of timely industry insight that take complex topics and makes them easier to digest and understand
Easy to understand summary and discussion of complex current topics.
ROC IT Solutions uses RxTrace to help keep abreast with the industry view(s) on the DQSA legislation and how companies are dealing with meeting the mandates. The views and insights are valuable to our assessment of how our product roadmap reacts to best serve our clients.
Been following RxTrace ever since some of the very first postings, and it’s one of my absolutely best sources of serious and thorough analyses, on an otherwise very delicate and complicated topic. Dirk’s writings and articles comes highly recommended, and I’m always looking forward to the next posting. Many thanks from Denmark for sharing your thoughts with us all.
Government and industry between them have made the issues surrounding traceablity and pedigree of medicines confused and fluid – RxTrace is my first choice when I want to untangle the history of these issues and to understand new developments.
Look forward to RxTrace News-helps me to better manage key issues
The knowledge presented in RxTrace, not simply the more common focus of the manufacturing, packaging, and regulatory requirements, but Dirk’s wholesale experience provides him with a complex view on the impacts to the end-to-end supply chain.
HBR: Artificial Intelligence Is Almost Ready for Business lnkd.in/bnPa4zy
Medical Device ID Effort Hits Snag on.wsj.com/1E9XkTY
Dirk A. Rodgers
March 9, 2015 (4:29)
DSCSA "Serial Numbers"Stephen, The DSCSA mandates serial numbers on Rx product only, and I do not t...
March 9, 2015 (4:18)
DSCSA "Serial Numbers"Will these DSCSA "Serial Numbers" be applied to OTC products as well as Rx?
Dirk A. Rodgers
February 27, 2015 (10:11)
Is An ASN Really The Best Way to Pass Lot-Based DSCSA Transaction Data?Marsha, Thanks for providing us with your company's real-world experience wit...
Dirk A. Rodgers
February 27, 2015 (10:02)
When Will The DSCSA Ever Require Investments In Aggregation?Sunil, Thanks for commenting. I share your concern about how the industry gr...
Marsha Flores Harris
February 26, 2015 (10:08)
Is An ASN Really The Best Way to Pass Lot-Based DSCSA Transaction Data?Dirk - Thanks for the discussion. What I've found from our customers, parti...